Search
for
Sort by
Research 781–810 of 1000+
- Mechanism exploration of the combined use of minoxidil with natural compounds ginsenoside Rg3 and glycyrrhizic acid for enhancing androgenic alopecia therapy
- Redox-Modulatory and MET-Inhibitory Triad: Synergistic Cytotoxicity of L-cysteine, NAC, and MET Inhibition in Cervical Cancer Cells
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Mechanistic Insights on Dyspepsia Modulation by Salvia rosmarinus Through Network Pharmacology, Molecular Docking, and Molecular Dynamics
- Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies
- The role of Wnt and Shh signaling systems in noggin-induced tumorigenesis
- Epigenetic mechanism of Gtl2-miRNAs causes the primitive sheep characteristics found in purebred Merino sheep
- Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal papilla cells
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss
- Molecular mechanisms of asymmetric divisions in mammary stem cells
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Mechanical and Immunological Regulation in Wound Healing and Skin Reconstruction
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Hoxc-Dependent Mesenchymal Niche Heterogeneity Drives Regional Hair Follicle Regeneration
- Tofacitinib therapy for children with severe alopecia areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Two Mechanisms Regulate Keratin K15 Expression In Keratinocytes: Role of PKC/AP-1 and FOXM1 Mediated Signalling
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Whole-genome bisulfite sequencing of goat skins identifies signatures associated with hair cycling
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates